Alphanox Co.,Ltd.

Informe acción KOSDAQ:A043100

Capitalización de mercado: ₩25.1b

AlphanoxLtd Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Seo-Kon Kim

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO24.6yrs
Participación del CEO5.1%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directivasin datos

Actualizaciones recientes de la dirección

Recent updates

Is Solco Biomedical (KOSDAQ:043100) Using Debt In A Risky Way?

Jun 27
Is Solco Biomedical (KOSDAQ:043100) Using Debt In A Risky Way?

Solco Biomedical Co., Ltd.'s (KOSDAQ:043100) 27% Dip In Price Shows Sentiment Is Matching Revenues

Jun 27
Solco Biomedical Co., Ltd.'s (KOSDAQ:043100) 27% Dip In Price Shows Sentiment Is Matching Revenues

Solco Biomedical Co., Ltd.'s (KOSDAQ:043100) Share Price Boosted 40% But Its Business Prospects Need A Lift Too

Feb 27
Solco Biomedical Co., Ltd.'s (KOSDAQ:043100) Share Price Boosted 40% But Its Business Prospects Need A Lift Too

CEO

Seo-Kon Kim (84 yo)

24.6yrs

Permanencia

Mr. Seo-Kon Kim has been Chief Executive Officer of Solco Biomedical Co. Ltd. since 2000. Mr. Kim has been Chief Executive Officer of Solco Law Firm since July 1995.Mr. Kim served as Chief of Sales Divisi...